The 3D-printed full-thickness artificial skin is an advanced 3D in vitro artificial skin model that accurately replicates both the epidermis and dermis. By enabling physiologically relevant interactions between these skin layers, this artificial skin platform plays a critical role in predicting drug efficacy. Unlike conventional epidermis-only skin models, the artificial skin model allows comprehensive analysis of epidermal proteins, dermal proteins, and proteins located at the epidermal–dermal interface.
Price | 3500€+ |
Organism | Human |
Product Type | 3D printed Full Thickness Skin |
Tissue | Skin |
Disease | – |
Applications
Safety & Toxicity test
Wound healing ability of pharmaceuticals and medical devices
Efficacy of functional cosmetics
With the global rise of K-beauty, the cosmetics industry continues to grow steadily. Since the ban on animal testing for cosmetics in Korea in 2017, various alternative testing methods have...
Traditional microscopy methods often require fluorescent labeling to analyze cellular structures, which can be time-consuming and invasive. In contrast, our HT-X1 system allows for high-resolution visualization of cellular morphology without...
Traditional protein analysis has primarily focused on quantifying expression levels within tissue samples. However, recent advances in spatial analysis techniques have shifted attention toward evaluating not only expression levels, but...
We conducted a study focused on identifying disease-related markers using patient-derived tissue samples. However, traditional methods limited our ability to analyze multiple candidate markers simultaneously, and the limited availability of...
Engineered using state-of-the-art 3D bioprinting technology and dECM (decellularized extracellular matrix) bio-ink, this artificial skin model precisely replicates the biomechanical properties and elasticity of human skin. By enabling quantitative assessment of skin elasticity dynamics, this innovation establishes a new scientific standard for the evaluation of cosmetic formulations and dermatological therapeutics.
Assess the approximate external appearance condition (visual reaction according to the substance)
Confirming the approximate reaction of the substance on OCT (Optical Coherence Tomography) (including epidermal formation and tissue thickness)
Leverage our 3D-printed full-thickness artificial skin platform to generate physiologically relevant data for drug and cosmetic testing. Contact Lambda Biologics to discuss your study design and testing needs.
Artificial skin is a 3D in vitro skin model designed to replicate the structure and biological functions of human skin. In drug testing, artificial skin is used to evaluate drug efficacy, safety, penetration, and biological responses without relying on animal models. By mimicking human epidermal and dermal architecture, artificial skin provides more physiologically relevant data compared to conventional 2D cell cultures.
A full-thickness artificial skin model incorporates both the epidermis and dermis, whereas epidermis-only models represent only the outer skin layer. The inclusion of the dermal compartment enables critical epidermal–dermal interactions, extracellular matrix (ECM) signaling, and fibroblast-mediated responses. As a result, full-thickness artificial skin models offer improved predictive accuracy for drug efficacy and skin biology compared to epidermis-only systems.
3D-printed artificial skin models provide precise control over tissue architecture, layer thickness, and cell distribution. This technology enhances reproducibility and scalability while enabling the creation of complex, physiologically relevant skin structures. For in vitro testing, 3D printing allows artificial skin models to closely resemble native human skin, improving consistency across experiments and supporting high-quality translational research.
Artificial skin models support the analysis of a wide range of biological markers, including epidermal differentiation markers, dermal fibroblast-associated proteins, extracellular matrix components, and proteins localized at the epidermal–dermal interface. This comprehensive protein profiling enables deeper insight into skin responses, tissue remodeling, and drug-induced biological effects that are not observable in traditional epidermal models.
Lambda Biologics’ artificial skin platform supports applications in drug efficacy testing, skin toxicity and irritation assessment, permeability studies, and cosmetic evaluation. The platform is designed for animal-free testing and provides a physiologically relevant in vitro system for pharmaceutical, biotechnology, and cosmetic research requiring advanced human skin models.
